Kelly Mills, MD

Neurologist Kelly Mills cares for patients who have movement disorders such as ataxia, dystonia, Parkinson’s disease, atypical parkinsonism and tremor. He evaluates and manages patients needing advanced therapies, such as deep brain stimulation, focused ultrasound or medication infusions to manage their movement symptoms. Additionally, he provides botulinum toxin treatment for various disorders. Dr. Mills earned his medical degree from the University of Maryland School of Medicine. He completed residency training in neurology at the University of California, San Francisco School of Medicine and remained there for fellowship training in movement disorders, which had a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills also holds a Master of Health Sciences from the Johns Hopkins Bloomberg School of Public Health. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might affect cognitive and psychiatric problems. He also works to develop new imaging biomarkers to detect mechanisms of disease, such as neuroinflammation in Parkinson’s disease.